Company Sanofi Deutsche Boerse AG

Equities

SNW

FR0000120578

Pharmaceuticals

Market Closed - Deutsche Boerse AG 06:59:38 03/05/2024 pm IST 5-day change 1st Jan Change
91.76 EUR -0.48% Intraday chart for Sanofi +0.50% +2.15%

Business Summary

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:

- pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases);

- human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas;

- consumer health products (12%).

At the end of 2023, the group had 54 production sites throughout the world.

Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).

Number of employees: 86,088

Sales per Business

EUR in Million2022Weight2023Weight Delta
Biopharma
88.0 %
30,688 71.4 % 37,890 88.0 % +23.47%
Consumer Healthcare
12.0 %
5,080 11.8 % 5,180 12.0 % +1.97%

Sales per region

EUR in Million2022Weight2023Weight Delta
United States
43.0 %
18,275 42.5 % 18,512 43.0 % +1.30%
Rest of the World
26.1 %
8,386 19.5 % 11,254 26.1 % +34.20%
Europe
18.6 %
7,703 17.9 % 8,013 18.6 % +4.02%
China
6.8 %
3,123 7.3 % 2,912 6.8 % -6.76%
France
5.5 %
2,296 5.3 % 2,379 5.5 % +3.61%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 01/19/01
Chief Operating Officer 40 01/22/01
Chief Tech/Sci/R&D Officer 51 -
Chief Tech/Sci/R&D Officer - 01/16/01
Chief Tech/Sci/R&D Officer 49 11/23/11
Chief Tech/Sci/R&D Officer - 01/19/01
Public Communications Contact - -
Corporate Officer/Principal - 01/20/01
- -
Corporate Officer/Principal 62 01/15/01

Members of the board

Members of the board TitleAgeSince
Director/Board Member 70 01/14/01
Director/Board Member 64 22/20/22
Chairman 60 02/22/02
Director/Board Member 52 28/20/28
Director/Board Member 61 03/13/03
Director/Board Member 66 03/22/03
Director/Board Member 53 03/22/03
Director/Board Member 56 30/21/30
Director/Board Member 58 01/21/01
Director/Board Member 56 01/21/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,264,799,969 1,101,935,715 ( 87.12 %) 13,450,388 ( 1.063 %) 87.12 %

Shareholders

NameEquities%Valuation
L'ORÉAL
9.348 %
118,227,307 9.348 % 11 614 M €
Amundi Asset Management SA (Investment Management)
3.533 %
44,679,241 3.533 % 4 389 M €
Dodge & Cox
1.780 %
22,512,304 1.780 % 2 212 M €
SANOFI
1.284 %
16,245,648 1.284 % 1 596 M €
Crédit Mutuel Asset Management SA
1.112 %
14,069,814 1.112 % 1 382 M €
Lyxor International Asset Management SAS
0.5764 %
7,289,777 0.5764 % 716 M €
Predica Prévoyance Dialogue du Crédit Agricole SA (Invt Port)
0.5390 %
6,817,764 0.5390 % 670 M €
Groupe des Assurances du Crédit Mutuel SA
0.5066 %
6,406,902 0.5066 % 629 M €
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.4711 %
5,959,024 0.4711 % 585 M €
Fédéral Finance Gestion SA
0.3907 %
4,942,080 0.3907 % 485 M €
NameEquities%Valuation
Dodge & Cox
3.093 %
78,250,193 3.093 % 3 803 M €
Fidelity Management & Research Co. LLC
0.8056 %
20,379,166 0.8056 % 990 M €
Fisher Asset Management LLC
0.5649 %
14,290,391 0.5649 % 695 M €
Boston Partners Global Investors, Inc.
0.5152 %
13,032,746 0.5152 % 633 M €
Merrill Lynch International
0.4056 %
10,260,690 0.4056 % 499 M €
Eaton Vance Management
0.3111 %
7,868,480 0.3111 % 382 M €
BNY Mellon Investment Adviser, Inc.
0.2856 %
7,224,829 0.2856 % 351 M €
Invesco Advisers, Inc.
0.2735 %
6,919,101 0.2735 % 336 M €
BlackRock Investment Management LLC
0.2165 %
5,477,302 0.2165 % 266 M €
Lee Munder Investments Ltd.
0.1844 %
4,663,598 0.1844 % 227 M €

Holdings

NameEquities%Valuation
16,245,648 1.28% 1,595,920,473 $
13,909,587 60.40% 1,353,934,300 $
EUROAPI
29.77%
28,298,074 29.77% 85,420,566 $
4,697,737 7.39% 28,515,264 $
1,919,455 7.30% 6,391,785 $
29,249 0.12% 545,225 $

Company contact information

Sanofi

46, avenue de la Grande Armée

75017, Paris

+33 1 53 77 40 00

http://www.sanofi.com
address Sanofi(SNW)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Medical Specialties
Pharmaceuticals: Major
Aventis, Inc.
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Biotechnology

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
91.3 EUR
Average target price
108.1 EUR
Spread / Average Target
+18.36%
Consensus